IL6 and central nervous system cancer: In vitro experiments have demonstrated that knockdown of TIM-1 expression inhibited the proliferation, migration, and invasion of glioma (U87, U251) cells and decreased the levels of TGF-β1, IL-6, IL-4, and IL-10 in gliomas.